Iverbendazole
Advanced Triple-Compound Research Formulation
Iverbendazole is an advanced research formulation that combines ivermectin, fenbendazole, and mebendazole into a single capsule. These three compounds have long-established roles as antiparasitic agents and have more recently attracted scientific interest for their potential biological effects beyond parasite management.
Additionally, researchers continue to investigate each ingredient individually and in combination for their influence on cellular metabolism, microtubule dynamics, immune signalling, and other biological pathways. However, these investigational areas remain under scientific evaluation and have not been approved as therapeutic indications.
How Iverbendazole Works
Iverbendazole combines three compounds with complementary mechanisms that researchers continue to investigate.
Ivermectin interacts with glutamate-gated chloride channels in parasites, while researchers also study its influence on cellular signalling pathways and immune modulation in laboratory models.
Fenbendazole and Mebendazole belong to the benzimidazole family and disrupt microtubule formation by binding to beta-tubulin. Consequently, they interfere with cellular structure and division in susceptible organisms. Furthermore, researchers continue to investigate these mechanisms in preclinical models exploring abnormal cell growth and cellular metabolism.
Together, these compounds have generated growing scientific interest because researchers are investigating their potential complementary activity across multiple biological pathways. Nevertheless, additional clinical research remains necessary to establish their safety and effectiveness for uses beyond their approved antiparasitic indications.
Benefits of Iverbendazole
- Combines three extensively studied antiparasitic compounds.
- Provides a convenient all-in-one capsule formulation.
- Investigated in preclinical research for microtubule function.
- Studied for potential effects on cellular metabolism.
- Explored for possible immunomodulatory activity.
- Investigated for effects on inflammatory signalling pathways.
- Supported by a growing body of laboratory research.
Ingredients & Product Information
Active Ingredients
Each capsule contains:
- Ivermectin – 12 mg
- Fenbendazole – 222 mg
- Mebendazole – 250 mg
Other Ingredients
- Gelatin capsule
- Microcrystalline cellulose
Product Information
- Product Type: Research formulation
- Form: Capsules
- Purity: ≥99% active ingredients (COA available on request)
Compound Information
Ivermectin
- CAS: 70288-86-7
- Molecular Formula: C₄₈H₇₄O₁₄
- Molecular Weight: 875.1 g/mol
- Synonym: Stromectol®
Fenbendazole
- CAS: 43210-67-9
- Molecular Formula: C₁₅H₁₃N₃O₂S
- Molecular Weight: 299.3 g/mol
- Synonym: Panacur®
Mebendazole
- CAS: 31431-39-7
- Molecular Formula: C₁₆H₁₃N₃O₃
- Molecular Weight: 295.2 g/mol
- Synonyms: Vermox®, Mebutar, MBZ, Mebezol
Directions For Using Iverbendazole
Take 1 capsule twice per day with water.
Storage & Handling
Store at room temperature, tightly sealed, away from heat, light and moisture.
Important Medical Disclaimer
This unregistered product has not been evaluated by SAHPRA for its safety, efficacy or intended use. It is not intended to treat, cure, diagnose or prevent any medical conditions.
Please consult with a healthcare professional prior to use if you are nursing, on medication or have a medical condition. Not intended for pregnant women.
